Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Delaying Alzheimer Disease Symptoms With Anti-Inflammatory Drugs

This study has been completed.
Sponsor:
Collaborator:
National Institute of Mental Health (NIMH)
Information provided by (Responsible Party):
Gary Small, MD, University of California, Los Angeles
ClinicalTrials.gov Identifier:
NCT00065169
First received: July 17, 2003
Last updated: December 2, 2015
Last verified: December 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2005
  Primary Completion Date: November 2005 (Final data collection date for primary outcome measure)